Sexl, Veronika

Assembly of cyclin D-dependent kinase and titration of p27 Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences

Cancer-related Molecular PathwaysProtein Kinase Regulation and GTPase Signaling

Cited by 496

Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity

Ni, J., Wang, X., Stojanovic, A., Zhang, Q., Wincher, M., Bühler, L., Arnold, A., Correia, M. P., Winkler, M., Koch, P.-S., et al. (2020) · Immunity

Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers

Cited by 324

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Kollmann, K., Heller, G., Schneckenleithner, C., Warsch, W., Scheicher, R., Ott, R. G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., et al. (2013) · Cancer Cell

Cancer-related Molecular PathwaysChronic Myeloid Leukemia Treatments

Cited by 313

Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression

Linke, M., Pham, H. T. T., Katholnig, K., Schnöller, T., Miller, A., Demel, F., Schütz, B., Rosner, M., Kovacic, B., Sukhbaatar, N., et al. (2017) · Nature Immunology

Sarcoidosis and Beryllium Toxicity ResearchTuberous Sclerosis Complex Research

Cited by 286

Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells

Streicher, C., Heyny, A., Andrukhova, O., Haigl, B., Slavic, S., Schüler, C., Kollmann, K., Kantner, I., Sexl, V., Kleiter, M., et al. (2017) · Scientific Reports

Bone Metabolism and DiseasesEstrogen and related hormone effects

Cited by 251

CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation

Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 204

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Porpaczy, E., Tripolt, S., Hoelbl-Kovacic, A., Gisslinger, B., Bago-Horvath, Z., Casanova-Hevia, E., Clappier, E., Decker, T., Fajmann, S., Fux, D. A., et al. (2018) · Blood

Myeloproliferative Neoplasms: Diagnosis and TreatmentLymphoma Diagnosis and Treatment

Cited by 151

DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune cell activation

Xiao, Q., Wu, J., Wang, W.-J., Chen, S., Zheng, Y., Yu, X., Meeth, K., Sahraei, M., Bothwell, A. L. M., Chen, L., et al. (2018) · Nature Medicine

Cancer Immunotherapy and BiomarkersWnt/β-catenin signaling in development and cancer

Cited by 130

NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development

Jelenčić, V., Šestan, M., Kavazović, I., Lenartić, M., Marinović, S., Holmes, T. D., Prchal-Murphy, M., Lisnić, B., Sexl, V., Bryceson, Y. T., et al. (2018) · Nature Immunology

Immune Cell Function and Interactioninterferon and immune responses

Cited by 62

NK Cell–Specific CDK8 Deletion Enhances Antitumor Responses

Witalisz-Siepracka, A., Gotthardt, D., Prchal-Murphy, M., Didara, Z., Menzl, I., Prinz, D., Edlinger, L., Putz, E. M., & Sexl, V. (2018) · Cancer Immunology Research

Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers

Cited by 47